ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Illex Guayusa

Also known as: Guayusa, Amazonian holly, Ilex guayusa

Overview

Ilex guayusa, commonly known as Guayusa, is a botanical supplement native to the Amazon rainforest, particularly Ecuador. Traditionally consumed as a tea by indigenous communities, it is valued for its stimulant and medicinal properties. The plant contains a rich profile of bioactive compounds, including xanthine alkaloids (such as caffeine), polyphenols, terpenes, and guanidine derivatives. Its primary uses revolve around providing mental and physical stimulation, offering antioxidant support, exhibiting anti-inflammatory effects, and showing potential metabolic benefits, especially in the context of diabetes management. While ethnobotanical and preclinical studies support its traditional applications, high-quality human clinical trials are currently limited, indicating an emerging but not yet fully validated scientific understanding of its full potential.

Benefits

Guayusa offers several potential benefits, primarily supported by preclinical and ethnobotanical evidence. Its metabolic effects are notable, with an animal study demonstrating that guayusa tea consumption mitigated hyperglycemia and improved autonomic cardiovascular modulation in diabetic rats. This suggests potential anti-diabetic properties, including stabilization of blood glucose levels and preservation of vascular sympathetic function. The plant is also rich in phenolic compounds and terpenes, contributing to its significant antioxidant and anti-inflammatory properties. These compounds help reduce oxidative stress and inflammation, which are factors in chronic diseases. Furthermore, due to its caffeine and other xanthine alkaloid content, guayusa acts as a mild stimulant, enhancing alertness and cognitive function, similar to other caffeinated teas. Traditional uses also suggest analgesic, antimicrobial, and phytohormonal activities, though these require further human validation.

How it works

The stimulant effects of Ilex guayusa are primarily attributed to caffeine and other xanthine alkaloids. These compounds act as antagonists to adenosine receptors in the central nervous system, leading to increased neuronal activity and enhanced alertness. Its potential anti-diabetic effects may involve guanidine derivatives, which are thought to act similarly to metformin by enhancing glucose uptake and improving insulin sensitivity, possibly through enzymatic inhibition related to endocannabinoid metabolism. The antioxidant activity is mediated by polyphenols and terpenes, which scavenge reactive oxygen species and modulate oxidative stress pathways. Additionally, observations in diabetic rats suggest guayusa may influence the balance of the autonomic nervous system, contributing to improved cardiovascular autonomic modulation, though the precise molecular targets for this effect are still being investigated.

Side effects

Ilex guayusa is generally considered safe when consumed as a tea in traditional amounts, with no significant adverse effects widely reported in ethnobotanical use. However, due to its stimulant properties, similar to caffeine, potential side effects may include insomnia, jitteriness, increased heart rate, or anxiety, particularly at high doses or in individuals sensitive to stimulants. There are currently no comprehensive human safety trials that meet rigorous clinical standards, meaning the full spectrum of potential side effects and their frequencies are not well-established. While no significant drug interactions or contraindications have been formally documented in the reviewed literature, caution is advised for individuals sensitive to caffeine, those with pre-existing cardiovascular conditions, or those taking medications for diabetes or other conditions, due to its potential metabolic effects. Pregnant or breastfeeding individuals should also exercise caution.

Dosage

There are no standardized dosing guidelines for Ilex guayusa due to the limited availability of human clinical data. Traditional consumption involves brewing approximately 3 grams of dried leaves per liter of water, which is then consumed ad libitum as a tea. The optimal dosage for achieving specific metabolic or other therapeutic effects has not yet been established through human randomized controlled trials. Absorption characteristics are likely similar to those of other caffeinated teas, with bioavailability potentially influenced by the preparation method and individual metabolic rates. Given its caffeine content, it is prudent to start with lower doses to assess individual tolerance and to avoid consumption late in the day to prevent sleep disturbances. Upper limits and safety thresholds for chronic use in humans are not well-defined.

FAQs

Is guayusa safe for daily consumption?

Traditional use suggests it is safe for daily consumption, but high-quality human safety data are limited. Individuals sensitive to caffeine should monitor their intake.

Does guayusa help with diabetes?

Animal studies indicate potential benefits in glycemic control and cardiovascular health in diabetic models, but human clinical trials are needed to confirm these effects.

How does guayusa compare to other caffeinated teas?

Guayusa contains caffeine and other stimulants similar to yerba mate and green tea, but it also possesses unique phytochemicals that may offer additional health benefits beyond stimulation.

Are there any known drug interactions?

No significant drug interactions are formally documented. However, caution is advised if combining with other stimulants or medications for diabetes or cardiovascular conditions.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11945722/ – This experimental randomized controlled trial in diabetic rats demonstrated that guayusa tea consumption over 21 days significantly reduced hyperglycemia progression and improved vascular sympathetic modulation. The study found a strong inverse correlation between improved vascular function and glycemia, suggesting potential anti-diabetic and cardiovascular benefits. Limitations include the small sample size and the use of an animal model, indicating a need for human studies.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC12251278/ – This comprehensive ethnobotanical and phytochemical review summarizes the traditional uses of guayusa, its bioactive compounds, and its pharmacological potential, including anti-diabetic, antioxidant, and stimulant effects. The review highlights the existing preclinical evidence and traditional knowledge but emphasizes the critical need for rigorous human clinical trials to validate these findings and establish efficacy and safety profiles.
  • https://www.rain-tree.com/guayusa.htm – This source provides general information on Ilex guayusa, focusing on its traditional uses and properties. It serves as a general reference for ethnobotanical context but does not present original research or clinical trial data. It supports the understanding of guayusa's historical and cultural significance.
  • https://www.fda.gov/files/food/published/GRAS-Notice-GRN-835-Ilex-guayusa-leaf-extract.pdf – This FDA GRAS (Generally Recognized As Safe) notice pertains to Ilex guayusa leaf extract. It provides a regulatory perspective on the safety of guayusa for use in food products, based on available scientific data and expert consensus. While not a clinical study, it indicates a level of safety assessment for specific applications.